Coachella’s mid-2010s star may have faded, but this year, the brand opportunity is as big as ever. In a crowded market, ...
CEO Rob Fried reveals Niagen Bioscience’s NAD+ growth strategy, from Tru Niagen to their upcoming telehealth launch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results